Cipla Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Cipla Ltd is ₹ 1388 as of 12 Jun 15:30 . The P/E Ratio of Cipla Ltd changed from 27.3 on March 2021 to 25.5 on March 2026 . This represents a CAGR of -1.13% over 6 yearsThe P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from -14 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 2 years The Market Cap of Cipla Ltd changed from ₹ 65746 crore on March 2021 to ₹ 98795 crore on March 2026 . This represents a CAGR of 7.02% over 6 yearsThe Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 4 years The revenue of Cipla Ltd for the Mar '26 is ₹ 6689 crore as compare to the Dec '25 revenue of ₹ 7280 crore. This represent the decline of -8.12% The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 1855 crore as compare to the Dec '25 revenue of ₹ 8.45 crore. This represent the growth of 21852% The ebitda of Cipla Ltd for the Mar '26 is ₹ 1103 crore as compare to the Dec '25 ebitda of ₹ 1185 crore. This represent the decline of -6.95% The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 1775 crore as compare to the Dec '25 ebitda of ₹ -69 crore. This represent the decline of -2672% The net profit of Cipla Ltd changed from ₹ 1176 crore to ₹ 550.11 crore over 8 quarters. This represents a CAGR of -31.61% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.9 crore to ₹ 1761 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Cipla Ltd changed from 16.34 % on March 2021 to 29.87 % on March 2026 . This represents a CAGR of 10.58% over 6 yearsThe Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Cipla Ltd

Cipla Limited is one of the leading pharmaceutical companies in India.
The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Limited was incorporated in year 1935 with the name as 'Chemical, Industrial & Pharmaceutical Laboratories Limited'.

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
The Company works on innovation and new product development for global markets.
They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Limited was incorporated on March 1, 2006 as an innovative and development company.
It commenced operations on March 22, 2006.
As per Scheme of Arrangement, the entire business undertaking of the Innovative Research & Development including Novel Drug Delivery System (NDDS) Division of Sun Pharmaceuticals Industries' Research & Development Undertaking was transferred and vested into the Company effective from February 28, 2007.

FAQs for the comparison of Cipla Ltd and Sun Pharma Advanced Research Company Ltd

Which company has a larger market capitalization, Cipla Ltd or Sun Pharma Advanced Research Company Ltd?

Market cap of Cipla Ltd is 112,193 Cr while Market cap of Sun Pharma Advanced Research Company Ltd is 7,249 Cr

What are the key factors driving the stock performance of Cipla Ltd and Sun Pharma Advanced Research Company Ltd?

The stock performance of Cipla Ltd and Sun Pharma Advanced Research Company Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cipla Ltd and Sun Pharma Advanced Research Company Ltd?

As of June 12, 2026, the Cipla Ltd stock price is INR ₹1388.8. On the other hand, Sun Pharma Advanced Research Company Ltd stock price is INR ₹223.4.

How do dividend payouts of Cipla Ltd and Sun Pharma Advanced Research Company Ltd compare?

To compare the dividend payouts of Cipla Ltd and Sun Pharma Advanced Research Company Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.